Very strange but 225,000 shares traded OTC in USa on Friday....

Very strange but 225,000 shares traded OTC in USa on Friday. Share price crossed upwards on 200 day average and has now confirmed breahout. Next stop in short term is 6 dollars. Seems that FDA approval coming within 30-90 day period could contine to appreciate share price as once approved and they gey 25 million ,Psivida will have 42 million in bank and looking at 50-60 cents eps nest year with projected 50%+ growth rates for forseeable future. This could explain sudden high volume interest in shares. AT 25xeps will egt to $13-15 share price by next year. However Pfizer must believe alot in technology as they are involved in other products which are FDA approved by the company and they are shareholder of 10%. If they buy Psivida we can get our price even sooner.